Security key
48669G204
KAZIA THERAPEUTICS LTD - SPONSORED ADS (KZIA)
CUSIP: 48669G204
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 321,669
- Total 13F value
- $568,691
- Share change
- +306,404
- SEC-reported price per share
- $1.77
- Number of holders
- 11
- Value change
- +$562,129
- Number of buys
- 11
- Number of sells
- 1
Report period
Q4 2024
Institutions
11
Top holders
10
KZIA full security history
Ownership snapshot
Full 13F holder table
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MAI Capital Management
Disclosed value leader
MAI Capital Management
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F
Highest disclosed value: $586,338
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MAI Capital Management has the largest disclosed position value at $586.3K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MAI Capital Management's linked filing trail.
Disclosed position value
Top 5
MAI Capital Management
$586.3K
UBS Group AG
$107.3K
MORGAN STANLEY
$94.7K
CITADEL ADVISORS LLC
$26K
JANE STREET GROUP, LLC
$19.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MAI Capital Management |
13F
Company
|
—
denominator unverified
|
$586,338
1,363,894 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$107,264
249,452 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$94,690
220,261 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$25,999
60,476 shares
|
— | 30 Sep 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$19,823
46,110 shares
|
— | 30 Sep 2024 |
| UNITED BANK |
13F
Company
|
—
denominator unverified
|
$18,916
44,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
321,669
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q4 2024 holders
11
Holder diff
10
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|